Ideal timing for testing: Before starting your GLP-1 medication (baseline) 4-6 weeks after starting treatment After any dose increase Quarterly during stable dosing Immediately if warning symptoms appear People at higher risk for electrolyte problems include those over 65, anyone with kidney disease, heart failure patients, people taking diuretics, and anyone with persistent GI symptoms lasting beyond the first 8-12 weeks of treatment
In de Amerikaanse productinformatie van orforglipron staan misselijkheid, verstopping, diarree en braken eveneens bovenaan, met daarnaast een waarschuwing over schildkliertumoren die bij proefdieren werden gezien
PD-1 + memory phenotype CD4 + T cells expressing C/EBPalpha underlie T cell immunodepression in senescence and leukemia
Adults who benefit from clinician-supervised medication management as part of a broader wellness plan
Katsumata R, Manabe N, Fujita M, Ayaki M, Sunago A, Kamada T, Monobe Y, Kawamoto H, Haruma K (2021) Colorectal neoplasms in melanosis coli: a survey in Japan and a worldwide meta-analysis
